Raymond James & Associates Matinas Bio Pharma Holdings, Inc. Transaction History

Raymond James & Associates

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$0.63 - $0.96 $13,860 - $21,120	-22,000 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$0.5 - $1.06 $4,250 - $9,010	8,500 Added 62.96%	22,000 $18,000
Q4 2021 Feb 08, 2022	BUY	$0.92 - $1.22 $12,420 - $16,470	13,500 New	13,500 $14,000
Q4 2019 Feb 12, 2020	SELL	$0.63 - $2.27 $10,710 - $38,590	-17,000 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$0.59 - $0.9 $2,655 - $4,050	4,500 Added 36.0%	17,000 $11,000
Q2 2019 Aug 06, 2019	BUY	$0.79 - $1.11 $9,875 - $13,875	12,500 New	12,500 $11,000

2.74M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $126M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.